Arvind Gupta
North America, California, United States, San Francisco
Description
Arvind Gupta co-leads Mayfield’s Engineering Biology practice. He was the first investor in breakout bio companies such as Geltor, Synthex,...
Investor Profile
Arvind Gupta has made 3 investments, with 0 in the past 12 months and 33% as lead.
Stage Focus
- Series A (33%)
- Series Unknown (33%)
- Seed (33%)
Country Focus
- United States (67%)
- United Kingdom (33%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Chemical
- Nanotechnology
- Marketing
- Medical Device
- Genetics
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
